Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Axe Compute Inc.AGPU · Entity 6706 | Director | October 01, 2026 | October 06, 2026 |
| Gritstone bio, Inc.GRTS · Entity 80946 | EVP, CHIEF BUSINESS OFFICER | May 15, 2024 | May 17, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Axe Compute Inc.
Report date October 01, 2026 · Filed October 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 14,176 |
Reported balance
After 2026-10-01 transaction · row 1
1 source rowRow 1 · 2026-10-01 · Grant · Acquired 733 · Balance 14,176 F1: Consists of 733 shares that were issued to the Reporting Person on October 1, 2026, as compensation for such Reporting Person's service on the Issuer's board of directors. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of 733 shares that were issued to the Reporting Person on October 1, 2026, as compensation for such Reporting Person's service on the Issuer's board of directors.
Gritstone bio, Inc.
Report date May 15, 2024 · Filed May 17, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 323,190 |
Reported balance
After 2024-05-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2024-05-15 · Grant · Acquired 19,149 · Balance 323,190 F1: Represents Performance Stock Units ("PSUs") granted on March 22, 2024 that were earned by the Reporting Person as a result of the achievement of certain performance criteria as certified by the Issuer's Board of Directors on May 15, 2024. The PSUs vest over one year; 1/2 vested on May 15, 2024, and thereafter the remaining 1/2 will vest on May 15, 2025, subject to the continuing service of the Reporting Person on such vesting date. Each PSU represents a contingent right to receive one share of the Issuer's Common Stock. F2: Includes 273,719 Restricted Stock Units ("RSUs") and PSUs which are subject to vesting. |
| Common StockSEC Table I · non-derivative | Direct | 313,931 |
Reported balance
After 2024-05-16 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2024-05-16 · Sale · Disposed 9,259 · Balance 313,931 F3: The sale of shares is for the sole purpose of covering the Reporting Person's tax liability with respect to the settlement of PSUs. F4: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.735 to $0.7616 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.75 · Expires 2034-05-14 | Direct | 180,000 |
Reported balance
After 2024-05-15 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-05-15 · Grant · Acquired 180,000 · Balance 180,000 F5: The option vests as to 1/2 of the total grant on September 30, 2024, with the remainder of grant vesting on September 30, 2025, subject to the continued service of the Reporting Person on each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents Performance Stock Units ("PSUs") granted on March 22, 2024 that were earned by the Reporting Person as a result of the achievement of certain performance criteria as certified by the Issuer's Board of Directors on May 15, 2024. The PSUs vest over one year; 1/2 vested on May 15, 2024, and thereafter the remaining 1/2 will vest on May 15, 2025, subject to the continuing service of the Reporting Person on such vesting date. Each PSU represents a contingent right to receive one share of the Issuer's Common Stock.
F2: Includes 273,719 Restricted Stock Units ("RSUs") and PSUs which are subject to vesting.
F3: The sale of shares is for the sole purpose of covering the Reporting Person's tax liability with respect to the settlement of PSUs.
F4: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.735 to $0.7616 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5: The option vests as to 1/2 of the total grant on September 30, 2024, with the remainder of grant vesting on September 30, 2025, subject to the continued service of the Reporting Person on each vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2026 Filed Oct 6, 2026 01:45 UTC | Axe Compute Inc. AGPU · Entity 6706 | GrantCommon Stock | 733 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-26-006426 · ownership.xml · nonDerivative · entry 1 Hawryluk Matthew · CIK 0001754470 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,176 F1 · shares: Consists of 733 shares that were issued to the Reporting Person on October 1, 2026, as compensation for such Reporting Person's service on the Issuer's board of directors. Read SEC document |
| July 01, 2026 Filed Sep 9, 2026 23:07 UTC | Axe Compute Inc. AGPU · Entity 6706 | GrantCommon Stock | 1,716 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-26-005960 · ownership.xml · nonDerivative · entry 1 Hawryluk Matthew · CIK 0001754470 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,443 F1 · shares: Consists of 1,716 shares that were issued to the Reporting Person on July 1, 2026, as compensation for such Reporting Person's service on the Issuer's board of directors. Read SEC document |
| April 20, 2026 Filed Apr 23, 2026 01:57 UTC | Axe Compute Inc. AGPU · Entity 6706 | GrantCommon Stock | 6,782 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-26-002659 · ownership.xml · nonDerivative · entry 1 Hawryluk Matthew · CIK 0001754470 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,727 F1 · shares: Consists of 3,078 shares issued to the Reporting Person on March 6, 2026, and 3,704 shares that were issued to the Reporting Person on April 20, 2026, in each case as compensation for such Reporting Person's service on the Issuer's board of directors. Read SEC document |
| September 09, 2025 Filed Sep 11, 2025 21:45 UTC | Axe Compute Inc. POAI · Entity 6706 | GrantCommon Stock | 64,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-25-005873 · ownership.xml · nonDerivative · entry 1 Hawryluk Matthew · CIK 0001754470 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,168 F1 · shares: The grant consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs shall vest in full on October 31, 2025, subject to continued service through the applicable vesting date. Read SEC document |
| May 16, 2024 Filed May 17, 2024 21:56 UTC | Gritstone bio, Inc. GRTS · Entity 80946 | SaleCommon Stock | 9,259 | $0.75 | $6,928.51 |
DisclosureSEC source: 0001415889-24-013654 · form4-05182024_010513.xml · nonDerivative · entry 2 Hawryluk Matthew · CIK 0001754470 · EVP, CHIEF BUSINESS OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 313,931 F3 · kind: The sale of shares is for the sole purpose of covering the Reporting Person's tax liability with respect to the settlement of PSUs. F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.735 to $0.7616 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 15, 2024 Filed May 17, 2024 21:56 UTC | Gritstone bio, Inc. GRTS · Entity 80946 | GrantStock Option (Right to Buy) · Derivative | 180,000 | $0.00 Strike: $0.75 | $0.00 |
DisclosureSEC source: 0001415889-24-013654 · form4-05182024_010513.xml · derivative · entry 3 Hawryluk Matthew · CIK 0001754470 · EVP, CHIEF BUSINESS OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 180,000 Underlying: Common Stock · 180,000 shares Expires 2034-05-14 F5 · derivative.exercise_date: The option vests as to 1/2 of the total grant on September 30, 2024, with the remainder of grant vesting on September 30, 2025, subject to the continued service of the Reporting Person on each vesting date. Read SEC document |
| May 15, 2024 Filed May 17, 2024 21:56 UTC | Gritstone bio, Inc. GRTS · Entity 80946 | GrantCommon Stock | 19,149 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-013654 · form4-05182024_010513.xml · nonDerivative · entry 1 Hawryluk Matthew · CIK 0001754470 · EVP, CHIEF BUSINESS OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 323,190 F1 · shares: Represents Performance Stock Units ("PSUs") granted on March 22, 2024 that were earned by the Reporting Person as a result of the achievement of certain performance criteria as certified by the Issuer's Board of Directors on May 15, 2024. The PSUs vest over one year; 1/2 vested on May 15, 2024, and thereafter the remaining 1/2 will vest on May 15, 2025, subject to the continuing service of the Reporting Person on such vesting date. Each PSU represents a contingent right to receive one share of the Issuer's Common Stock. F2 · balance_after: Includes 273,719 Restricted Stock Units ("RSUs") and PSUs which are subject to vesting. Read SEC document |
| April 05, 2024 Filed Apr 12, 2024 21:26 UTC | Axe Compute Inc. POAI · Entity 6706 | GrantCommon Stock | 2,368 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-24-002004 · ownership.xml · nonDerivative · entry 1 Hawryluk Matthew · CIK 0001754470 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,488 Read SEC document |
| February 01, 2024 Filed Feb 5, 2024 19:22 UTC | Gritstone bio, Inc. GRTS · Entity 80946 | GrantStock Option (Right to Buy) · Derivative | 180,000 | $0.00 Strike: $2.46 | $0.00 |
DisclosureSEC source: 0001415889-24-002738 · form4-02062024_120215.xml · derivative · entry 2 Hawryluk Matthew · CIK 0001754470 · EVP, CHIEF BUSINESS OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 180,000 Underlying: Common Stock · 180,000 shares Expires 2034-01-31 F3 · derivative.exercise_date: The option vests as to 1/24th of the total grant monthly beginning February 1, 2024 until such time as the option is 100% vested, subject to the continued service of the Reporting Person on each vesting date. Read SEC document |
| February 01, 2024 Filed Feb 5, 2024 19:22 UTC | Gritstone bio, Inc. GRTS · Entity 80946 | GrantCommon Stock | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-002738 · form4-02062024_120215.xml · nonDerivative · entry 1 Hawryluk Matthew · CIK 0001754470 · EVP, CHIEF BUSINESS OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 286,880 F1 · shares: Represents Restricted Stock Units ("RSUs") of which 1/2 vests on the first anniversary of the grant date, with the remainder of grant vesting on the second anniversary of the grant date, subject to the continued service of the Reporting Person on each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F2 · balance_after: Includes 20,730 shares of Common Stock purchased under the Issuer's Employee Stock Purchase Plan in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c) and 209,610 RSUs which are subject to vesting. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 21:03 UTC | Axe Compute Inc. POAI · Entity 6706 | GrantCommon Stock | 1,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-23-006098 · ownership.xml · nonDerivative · entry 1 Hawryluk Matthew · CIK 0001754470 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,135 Read SEC document |
| July 03, 2023 Filed Jul 5, 2023 13:03 UTC | Axe Compute Inc. POAI · Entity 6706 | GrantCommon Stock | 2,675 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-23-004326 · ownership.xml · nonDerivative · entry 1 Hawryluk Matthew · CIK 0001754470 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,260 Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 17:03 UTC | Axe Compute Inc. POAI · Entity 6706 | GrantCommon Stock | 18,360 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-006254 · form4-04052023_050445.xml · nonDerivative · entry 1 Hawryluk Matthew · CIK 0001754470 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,692 Read SEC document |
| February 02, 2023 Filed Feb 6, 2023 17:29 UTC | Gritstone bio, Inc. GRTS · Entity 80946 | GrantCommon Stock | 191,771 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-23-001945 · doc1.xml · nonDerivative · entry 1 Hawryluk Matthew · CIK 0001754470 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248,311 F1 · shares: Represents Restricted Stock Units ("RSUs") 137,291 of which vest semi-annually over four years and 54,480 of which vest annually over two years from February 1, 2023, in each case, subject to the Reporting Person's continuous service to the Issuer on each such date. Each RSU represents a contingent right to receive one share of common stock of the Issuer. F2 · balance_after: Includes 3,189 shares of common stock purchased under the Issuer's Employee Stock Purchase Plan in transactions exempt from Section 16(b) pursuant to Rule 16b-3(c) and 191,771 RSUs which are subject to vesting. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 18:21 UTC | Axe Compute Inc. POAI · Entity 6706 | GrantCommon Stock | 19,570 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-000217 · form4-01042023_060117.xml · nonDerivative · entry 1 Hawryluk Matthew · CIK 0001754470 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,332 Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 16:18 UTC | Axe Compute Inc. POAI · Entity 6706 | GrantCommon Stock | 13,762 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-012024 · form4-12052022_041257.xml · nonDerivative · entry 1 Hawryluk Matthew · CIK 0001754470 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,762 Read SEC document |
| January 31, 2022 Filed Apr 20, 2022 16:32 UTC | Gritstone bio, Inc. GRTS · Entity 80946 | GrantStock Option (Right to Buy) · Derivative | 129,675 | $0.00 Strike: $5.46 | $0.00 |
DisclosureSEC source: 0001567619-22-008716 · doc1.xml · derivative · entry 2 Hawryluk Matthew · CIK 0001754470 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,675 Underlying: Common Stock · 129,675 shares Expires 2032-01-30 F3 · derivative.exercise_date: One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from January 31, 2022 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date. Read SEC document |
| January 31, 2022 Filed Apr 20, 2022 16:32 UTC | Gritstone bio, Inc. GRTS · Entity 80946 | GrantCommon Stock | 21,612 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-008716 · doc1.xml · nonDerivative · entry 1 Hawryluk Matthew · CIK 0001754470 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,351 F1 · shares: Represents Restricted Stock Units ("RSUs") which vest on the first anniversary of the grant date. Each RSU represents a contingent right to receive one share of common stock of the Issuer. F2 · balance_after: Includes 12,139 shares of common stock purchased under the Issuer's Employee Stock Purchase Plan in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c) and 31,412 RSUs which vest over time measured from the grant date. Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 17:09 UTC | Gritstone bio, Inc. GRTS · Entity 80946 | GrantStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $13.87 | $0.00 |
DisclosureSEC source: 0001567619-21-005996 · doc1.xml · derivative · entry 1 Hawryluk Matthew · CIK 0001754470 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2031-03-07 F1 · derivative.exercise_date: One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 8, 2021 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date. Read SEC document |
| January 07, 2021 Filed Nov 19, 2021 16:45 UTC | Gritstone bio, Inc. GRTS · Entity 80946 | GrantCommon Stock | 19,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-020856 · doc1.xml · nonDerivative · entry 1 Hawryluk Matthew · CIK 0001754470 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,198 F1 · shares: Represents Restricted Stock Units ("RSUs") which vest in two equal annual installments over a two year period measured from the grant date. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. F2 · balance_after: Includes 4,598 shares of common stock purchased under the Issuer's Employee Stock Purchase Plan in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c) and 19,600 RSUs which vest over time measured from the grant date. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 17:27 UTC | Gritstone bio, Inc. GRTS · Entity 80946 | GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $8.91 | $0.00 |
DisclosureSEC source: 0001567619-20-005030 · doc1.xml · derivative · entry 1 Hawryluk Matthew · CIK 0001754470 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2030-02-24 F1 · derivative.exercise_date: The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on March 1, 2020. Read SEC document |
| February 13, 2019 Filed Mar 14, 2019 19:18 UTC | Gritstone bio, Inc. GRTS · Entity 80946 | GrantStock Option (Right to Buy) · Derivative | 55,000 | $0.00 Strike: $12.02 | $0.00 |
DisclosureSEC source: 0001567619-19-006918 · doc1.xml · derivative · entry 1 Hawryluk Matthew · CIK 0001754470 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 55,000 shares Expires 2029-02-12 F1 · derivative.exercise_date: The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on March 1, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.